Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.6% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
2
users have commented on this narrative
41
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.3% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
16
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Hexagon Purus
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Green Hydrogen Delays Will Dampen Market Potential Amid Battery Competition
Key Takeaways Overreliance on government incentives and slow hydrogen infrastructure adoption threaten revenue stability, while intensifying battery-electric competition challenges long-term market potential. High R&D spending, ongoing restructuring, and volatile industry conditions undermine profitability and risk further shareholder dilution without margin or cash flow improvement.
View narrative
NOK 1.70
FV
5.9% overvalued
intrinsic discount
17.32%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Alector
AN
AnalystLowTarget
Consensus Narrative from 7 Analysts
Overvaluation Will Deflate Prospects In A Niche Neurology Market
Key Takeaways Alector's limited target market and intense pricing pressures threaten future revenue growth and profit potential, even with successful regulatory outcomes. Persistent financial losses and competition from larger biotech firms increase risks of dilution, delays, and challenges in attracting resources and partnerships.
View narrative
US$1.00
FV
125.0% overvalued
intrinsic discount
-43.27%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Inseego
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Fierce Pricing Battles And Commoditized Hardware Will Erode Standalone Relevance
Key Takeaways Intense competition and industry shifts toward integrated solutions threaten Inseego's market relevance, margins, and long-term earnings stability. Heavy dependence on a few customers and slow progress in transitioning to recurring software revenue expose the company to volatile growth and margin risk.
View narrative
US$8.00
FV
7.6% overvalued
intrinsic discount
4.43%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
WildBrain
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Dependence On Legacy Brands And Rising Costs Will Constrain Performance
Key Takeaways Audience and revenue declines from shifting viewer habits, brand fatigue in legacy IPs, and rising costs threaten long-term growth and earnings stability. Growing regulatory restrictions and platform competition put further pressure on margins, reinvestment capacity, and digital revenue streams.
View narrative
CA$1.75
FV
0.6% overvalued
intrinsic discount
7.38%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Alta Equipment Group
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
Automation And Electrification Will Diminish Equipment Demand With Small Recovery
Key Takeaways Rapid technological shifts and stricter regulations threaten Alta's traditional equipment value, forcing costly upgrades and risking diminished margins. High debt and increased competition may erode earnings, while compliance demands drive up costs and constrain potential profitability.
View narrative
US$8.00
FV
0.3% overvalued
intrinsic discount
3.51%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Healwell AI
AN
AnalystLowTarget
Consensus Narrative from 11 Analysts
Integration And Compliance Woes Will Hamper Healthtech Yet Spark Recovery
Key Takeaways Integration challenges from acquisitions and regulatory hurdles may delay cost savings and limit the scalability of Healwell's AI healthcare offerings in new markets. High R&D spending and variable revenue streams could constrain profit margins and make earnings less predictable despite strong industry tailwinds and government support.
View narrative
CA$2.50
FV
46.4% undervalued
intrinsic discount
73.61%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Inogen
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Pricing Pressures And Rivals Will Erode Portable Oxygen Margins
Key Takeaways Heightened pricing pressures, commoditization risks, and more low-cost competitors threaten Inogen's market share, margins, and ability to sustain growth. Shifting technology trends, declining gross margins, and stricter regulatory requirements may further erode profitability without significant innovation or efficiency gains.
View narrative
US$7.00
FV
6.6% overvalued
intrinsic discount
6.09%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Motorcar Parts of America
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Rising Vehicle Longevity And Remanufacturing Will Expand Market Opportunities
Key Takeaways Growth in older vehicles and nondiscretionary repairs is supporting strong sales, cash flow, and expanding MPAA's market opportunities. New product expansion, operational efficiencies, and demand for remanufactured parts are expected to boost margins and secure long-term revenue stability.
View narrative
US$18.00
FV
23.7% undervalued
intrinsic discount
6.21%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
Updated
narrative
Oneview Healthcare
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Digital Transformation Will Expand Interoperable Patient Care Systems
Key Takeaways Accelerating project deployments, strategic partnerships, and advanced product offerings position the company for rapid market expansion, revenue growth, and increased operational leverage. Deep integration, high customer retention, and ecosystem advantages drive long-term earnings predictability and a stronger path to profitability than anticipated.
View narrative
AU$0.57
FV
58.0% undervalued
intrinsic discount
53.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Value any company in seconds
Popular companies